Contribution of gut contents, intestinal wall and liver to the first-pass metabolism of clonazepam in the rat. - Suppr | 超能文献

Contribution of gut contents, intestinal wall and liver to the first-pass metabolism of clonazepam in the rat.

作者信息

Colburn W A, Bekersky I, Min B H, Hodshon B J, Garland W A

出版信息

Res Commun Chem Pathol Pharmacol. 1980 Jan;27(1):73-90.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Contribution of gut contents, intestinal wall and liver to the first-pass metabolism of clonazepam in the rat.

Res Commun Chem Pathol Pharmacol. 1980 Jan;27(1):73-90.

2

Role of the intestinal microflora in clonazepam metabolism in the rat.肠道微生物群在大鼠氯硝西泮代谢中的作用。

Xenobiotica. 1984 Nov;14(11):829-40. doi: 10.3109/00498258409151481.

3

Proceedings: Blood level, excretion, distribution and metabolism of 14C-triflubazam, a new 1,5-benzodiazepine, in mice and dogs.研究报告：新型1,5-苯二氮䓬类药物14C-三氟巴嗪在小鼠和犬体内的血药浓度、排泄、分布及代谢情况

Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R6.

4

Role of gut contents, intestinal wall, and liver on the first pass metabolism and absolute bioavailability of isotretinoin in the dog.肠道内容物、肠壁和肝脏对异维A酸在犬体内首过代谢及绝对生物利用度的作用。

Drug Metab Dispos. 1983 Sep-Oct;11(5):458-62.

5

In vivo O-de-ethylation of phenacetin in 3-methylcholanthrene-pretreated rats: gut wall and liver first-pass metabolism.

J Pharmacol Exp Ther. 1983 Apr;225(1):153-7.

6

Pharmacokinetics of clonazepam in the dog.氯硝西泮在犬体内的药代动力学

Arch Int Pharmacodyn Ther. 1984 Apr;268(2):180-93.

7

Pharmacokinetic profile of clonazepam in rhesus monkeys.氯硝西泮在恒河猴体内的药代动力学特征。

J Pharm Sci. 1978 Mar;67(3):295-9. doi: 10.1002/jps.2600670304.

8

Hepatic and intestinal first-pass effects of oltipraz in rats.奥替普拉在大鼠体内的肝脏和肠道首过效应。

Biopharm Drug Dispos. 2005 May;26(4):129-34. doi: 10.1002/bdd.439.

9

Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.昂丹司琼在大鼠体内的非剂量依赖性药代动力学：肝脏和肠道首过效应对低生物利用度的影响

Biopharm Drug Dispos. 2008 Oct;29(7):414-26. doi: 10.1002/bdd.628.

10

Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.大鼠静脉注射和口服西地那非后的药代动力学：肝脏和肠道的首过效应。

Int J Pharm. 2006 Aug 31;320(1-2):64-70. doi: 10.1016/j.ijpharm.2006.04.005. Epub 2006 May 26.

引用本文的文献

1

Insights from pharmacokinetic models of host-microbiome drug metabolism.宿主-微生物药物代谢的药代动力学模型的见解。

Gut Microbes. 2020 May 3;11(3):587-596. doi: 10.1080/19490976.2019.1667724. Epub 2019 Sep 29.

2

Comparative pharmacokinetics of benzodiazepines in dog and man.苯二氮䓬类药物在犬和人类体内的比较药代动力学。

J Pharmacokinet Biopharm. 1982 Aug;10(4):411-26. doi: 10.1007/BF01065172.